![]() ![]() Ryan TJ, Antman EM, Brooks NH, et al.: 1999 update: ACC/ AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Loubeyre C, Morice M, Lefevre T, et al.: A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. Montalescot G, Barragan P, Wittenberg O, et al.: Angioplasty AIAbD, Stenting in Myocardial Infarction Regarding A, Long- Term F-u. Kiemeneij F, Serruys PW, Macaya C, et al.: Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. First trial to demonstrate a benefit of early angiography in ACS. Wallentin L, Lagerqvist B, Husted S, et al.: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. 1995, 26:1643–1650.īoden WE, O’Rourke RA, Crawford MH, et al.: Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. Initial trial comparing early invasive and conservative strategies.Īnderson HV, Cannon CP, Stone PH, et al.: One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. The TIMI IIIB Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Yusuf S, Flather M, Pogue J, et al.: Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. A randomized comparison between unfractionated and lowmolecular- weight heparin. N Engl J Med 1992, 327:141–145.īijsterveld NR, Moons AH, Meijers JC, et al.: Rebound thrombin generation after heparin therapy in unstable angina. Theroux P, Waters D, Lam J, et al.: Reactivation of unstable angina after the discontinuation of heparin. ![]() Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. N Engl J Med 1997, 337:447–452.Īntman EM, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina/ non-Q-wave myocardial infarction. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. 2000, 101:570–580.Ĭohen M, Demers C, Gurfinkel EP, et al.: A comparison of lowmolecular- weight heparin with unfractionated heparin for unstable coronary artery disease. Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Theroux P, Fuster V: Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Important guidelines on the management of ACS. A report of the American College of Cardiology/American Heart Association task force on practice. 1999, 354:708–715.īraunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. The FRISC II Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. First trial to compare early invasive and conservative strategies in ACS patients treated with the intravenous GP IIb/IIIa antagonists, tirofiban. 2001, 37:342A.Ĭannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Stone GW, Grines CL, Cox DA, et al.: A prospective, multicenter, international randomized trial comparing four perfusion strategies in acute myocardial infarction: Principal report of the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Stent Primary Angioplasty in Myocardial Infarction Study Group. Grines CL, Cox DA, Stone GW, et al.: Coronary angioplasty with or without stent implantation for acute myocardial infarction. ![]() The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |